Drug discovery using chemical systems biology: repositioning the safe medicine Comtan to treat multi-drug and extensively drug resistant tuberculosis.
The rise of multi-drug resistant (MDR) and extensively drug resistant (XDR) tuberculosis around the world, including in industrialized nations, poses a great threat to human health and defines a need to develop new, effective and inexpensive anti-tubercular agents. Previously we developed a chemical...
Guardado en:
Autores principales: | Sarah L Kinnings, Nina Liu, Nancy Buchmeier, Peter J Tonge, Lei Xie, Philip E Bourne |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/64c00c83b6504f478fcb12e42c5a243c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Prediction of drug-target interactions and drug repositioning via network-based inference.
por: Feixiong Cheng, et al.
Publicado: (2012) -
Drug Repositioning For Allosteric Modulation of VIP and PACAP Receptors
por: Ingrid Langer, et al.
Publicado: (2021) - Drug Discovery
-
New approaches to filling the gap in tuberculosis drug discovery.
por: Martina Casenghi, et al.
Publicado: (2007) -
Evaluation of connectivity map shows limited reproducibility in drug repositioning
por: Nathaniel Lim, et al.
Publicado: (2021)